TY  - GEN
AU  - Font,A
AU  - Sanchez,J M
AU  - Rosell,R
AU  - Taron,M
AU  - Martinez,E
AU  - Guillot,M
AU  - Manzano,J L
AU  - Margeli,M
AU  - Barnadas,A
AU  - Abad,A
TI  - Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors
SN  - 0169-5002
PY  - 2003///0207
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Camptothecin
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Carcinoma, Small Cell
KW  - Carcinoma, Squamous Cell
KW  - Docetaxel
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Irinotecan
KW  - Lung Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Review
UR  - https://doi.org/10.1016/s0169-5002(02)00081-8
ER  -